Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORMAT TECHNOLOGIES, INC. Director's Dealing 2025

Oct 3, 2025

6968_rns_2025-10-03_88ae5a5e-560f-4127-b268-7dbd263e77d7.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

X transaction was made pursuant to a
contract, instruction or written plan for the
purchase or sale of equity securities of
the issuer that is intended to satisfy the
affirmative defense conditions of Rule
10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Woelfel
Jessica
2. Issuer Name and Ticker or Trading Symbol
ORMAT TECHNOLOGIES, INC. [ ORA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
(Last) (First)
C/O ORMAT TECHNOLOGIES, INC.
6884 SIERRA CENTER PARKWAY
(Middle) 3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025
X Director
Officer (give title
below)
GC, CCO, and CS
10% Owner
Other (specify
below)
(Street)
RENO
NV
89511
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)
X
Form filed by One Reporting Person
Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)
2. Transaction Date
(Month/Day/Year)
2A. Deemed
Execution Date, if
any
(Month/Day/Year)
3.
Transaction
Code (Instr.
8)
4. Securities Acquired (A)
or Disposed Of (D) (Instr. 3,
4 and 5)
5. Amount of
Securities
Beneficially
Owned Following
6.
Ownership
Form:
Direct (D) or
7. Nature of
Indirect
Beneficial
Ownership
Code V Amount (A)
or
(D)
Price Reported
Transaction(s)
(Instr. 3 and 4)
Indirect (I)
(Instr. 4)
(Instr. 4)
Common Stock 09/29/2025 M(1) 6,401 A \$78.53 11,635 D
Common Stock 09/29/2025 D 5,291(2) D \$95.00 6,344 D
Common Stock
09/29/2025
M(3) 10,000 A \$69.14 15,234 D

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a

Common Stock 09/29/2025 D 7,300(4) D \$94.64 7,934 D
Common Stock 09/29/2025 S
(5)
5,611 \$94.80(6) 3,433 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of
Derivative
Security (Instr.
3)
2.
Conversio
n or
Exercise
Price of
Derivative
3. Transaction
Date
(Month/Day/Yea
r)
3A. Deemed
Execution Date,
if any
(Month/Day/Yea
r)
4.
Transacti
on Code
(Instr. 8)
5. Number of
Derivative
Securities
Acquired (A) or
Disposed of (D)
(Instr. 3, 4 and 5)
6. Date
Exercisable and
Expiration Date
(Month/Day/Year
)
7. Title and Amount
of Securities
Underlying Derivative
Security (Instr. 3 and
4)
8.
Price
of
Derivat
ive
Securit
9.
Number
of
derivative
Securities
Beneficial
10.
Ownershi
p Form:
Direct (D)
or Indirect
(I) (Instr.
11. Nature
of Indirect
Beneficial
Ownershi
p (Instr. 4)
Security Code V (A) (D) Date
Exercis
able
Expiratio
n Date
Title Amount
or
Number
of Shares
y
(Instr.
5)
ly Owned
Following
Reported
Transacti
on(s)
(Instr. 4)
4)
Stock Appreciation
Rights (SARs)
\$78.53 09/29/2025 M 6,401 03/31/2
023
03/31/20
27
Common
Stock
6,401 \$0 0 D
Stock Appreciation
Rights (SARs)
\$69.14 09/29/2025 M 10,000 06/15/2
02
06/15/20
26
Common
Stock
10,000 \$0 0 D

Explanation of Responses:

    1. Represents the exercise of Stock Appreciation Rights ("SARs") expiring on March 31, 2027, for which the reporting person exercised all 6,401 shares.
    1. This represents the difference between the number of SARs exercised (6,401) and the number of shares issued as a result of the exercise (1,110) The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise (\$95.00) and the exercise price (\$78.53).
    1. Represents the exercise of SARs expiring on June 15, 2026, for which the reporting person exercised all 10,000 shares.
    1. This represents the difference between the number of SARs exercised (10,000) and the number of shares issued as a result of the exercise (2,700). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise (\$94.64) and the exercise price (\$69.14).
    1. Represents shares of common stock sold in the open market on September 29, 2025 pursuant to a 10b5-1 Plan adopted by the reporting person on 06/30/2025.
  • The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from \$94.36 to \$95.00, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range specified herein.

Remarks:

/s/ Jessica Woelfel 9/30/2025

** Signature of Reporting Person Date